Daily as of 3 Nov 16:00 ET
- Price
- above both $127.09 vs 50 $115.19 / 200 $96.99
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 14 Jul 2025 · projected 27 bars out
KYMR | Kymera TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$127.09
-$0.42 (-0.33%)
Kymera Therapeutics (KYMR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat above the 200 on the daily since Jul 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $126.63 vs 50 $92.70 / 200 $49.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 28 Oct 2024 · projected 22 bars out · tested 1 bar
4-hour as of 3 Nov 16:00 ET
- Price
- above both $127.09 vs 50 $113.16 / 200 $112.36
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 25 Jun 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 25 Jun 2026 | 🟨Golden | 4-hour | 30 bars out | Not tested |
| 3 Jun 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 14 Jul 2025 | 🟨Golden steep | daily | 27 bars out | Not tested |
| 6 Jun 2025 | 🟨Golden | 4-hour | 14 bars out | — |
| 11 Feb 2025 | 💀Death | daily | 11 bars out | Not tested |
About KYMR
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$80.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid